Protalix BioTherapeutics, Inc. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
Protalix BioTherapeutics, Inc. (PLX) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$1.18 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-03-18
- Protalix BioTherapeutics, Inc. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was -$1.18M, a 235.09% decline from fiscal 2024.
- Protalix BioTherapeutics, Inc. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was $872.00K, a 51.53% decline from fiscal 2023.
- Protalix BioTherapeutics, Inc. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was $1.80M.
- Protalix BioTherapeutics, Inc. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2022 was -$3.02M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month |
|---|---|
| 2025-12-31 | -$1.18M 10-K · filed 2026-03-18 |
| 2024-12-31 | $872.00K 10-K · filed 2026-03-18 |
| 2023-12-31 | $1.80M 10-K · filed 2026-03-18 |
| 2022-12-31 | -$3.02M 10-K · filed 2025-03-17 |
| 2021-12-31 | -$5.79M 10-K · filed 2024-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |